Table 1

Demographic and clinical characteristics of the 527 RA patients

Per centMean (SD)
Inclusion age, years57 (15)
Disease duration, months6.2 (3.2)
Ever smokers55
Rheumatoid factorPositive60
VAS pain (0–10 cm)4.5 (2.4)
DAS285.23 (1.2)
CRP (mg/L)35 (37)
Tender joint count (28 joints)8 (6)
Swollen joint count (28 joints)11 (6)
VAS PatGA (0–10 cm)4.4 (2.5)
VAS PhGA (0–10 cm)4.8 (1.7)
HAQ (0–3)1.0 (0.65)
SHS (median (IQR))1 (0–4.5)
  • Anti-CCP, antibodies to citrullinated peptides; CRP, C reactive protein; DAS28, disease activity score calculated on 28 joints; HAQ, Health Assessment Questionnaire; PatGA, patients global assessment; PhGA, physician's global assessment; MTX, methotrexate; RA, rheumatoid arthritis; SHS, Sharp van der Heijde total Score; SAL, sulfasalazine; VAS, visual analogue scale.